Ken Aizawa
Kamakura, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Prolonged Duration of Erythropoiesis-Stimulating Agents' Action Delays Disease Progression in Anti-Thy 1 Antibody-Induced Chronic Glomerulonephritis Rats.
Journal: Pharmacology
Published: October 10, 2019
Epoetin beta pegol for treatment of anemia ameliorates deterioration of erythrocyte quality associated with chronic kidney disease.
Journal: BMC nephrology
Published: February 13, 2017
Epoetin beta pegol alleviates oxidative stress and exacerbation of renal damage from iron deposition, thereby delaying CKD progression in progressive glomerulonephritis rats.
Journal: Physiological reports
Published: December 05, 2015
Epoetin beta pegol, but not recombinant erythropoietin, retains its hematopoietic effect in vivo in the presence of the sialic acid-metabolizing enzyme sialidase.
Journal: International journal of hematology
Published: November 12, 2015
Eldecalcitol prevents endothelial dysfunction in postmenopausal osteoporosis model rats.
Journal: The Journal of endocrinology
Published: November 03, 2015
Epoetin beta pegol prevents endothelial dysfunction as evaluated by flow-mediated dilation in chronic kidney disease rats.
Journal: European journal of pharmacology
Published: April 14, 2015
Nicorandil prevents sirolimus-induced production of reactive oxygen species, endothelial dysfunction, and thrombus formation.
Journal: Journal of pharmacological sciences
Published: August 26, 2014
Renoprotective effect of epoetin beta pegol by the prevention of M2 macrophage recruitment in Thy-1 rats.
Journal: Journal of nephrology
Published: March 17, 2014
Vitamin D receptor signaling enhances locomotive ability in mice.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: October 17, 2013
22-Oxacalcitriol prevents progression of endothelial dysfunction through antioxidative effects in rats with type 2 diabetes and early-stage nephropathy.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: December 15, 2012
Renoprotection by continuous erythropoietin receptor activator in puromycin aminonucleoside-induced nephrotic syndrome.
Journal: American journal of nephrology
Published: August 16, 2012
Last Updated: 09/26/2026